BeOne Medicines (ONC) Assets: 2015-2025
Historic Assets for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $7.6 billion.
- BeOne Medicines' Assets rose 30.90% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year increase of 30.90%. This contributed to the annual value of $5.9 billion for FY2024, which is 1.99% up from last year.
- Per BeOne Medicines' latest filing, its Assets stood at $7.6 billion for Q3 2025, which was up 21.18% from $6.3 billion recorded in Q2 2025.
- BeOne Medicines' 5-year Assets high stood at $8.5 billion for Q4 2021, and its period low was $5.3 billion during Q3 2021.
- Over the past 3 years, BeOne Medicines' median Assets value was $5.8 billion (recorded in 2024), while the average stood at $6.0 billion.
- As far as peak fluctuations go, BeOne Medicines' Assets soared by 52.40% in 2021, and later slumped by 35.78% in 2022.
- BeOne Medicines' Assets (Quarterly) stood at $8.5 billion in 2021, then tumbled by 35.78% to $5.5 billion in 2022, then rose by 5.91% to $5.8 billion in 2023, then grew by 1.99% to $5.9 billion in 2024, then spiked by 30.90% to $7.6 billion in 2025.
- Its Assets was $7.6 billion in Q3 2025, compared to $6.3 billion in Q2 2025 and $5.8 billion in Q1 2025.